Insurances & Business

Genentech, Biogen shares dip on late-stage drug failure (AP)

Business | Sources: Yahoo

Similar/Related/News:

• Novartis shares jump as cancer drug shows promise (AP)
Shares of drug developer Novartis AG jumped Monday after the company said its kidney cancer drug candidate delayed tumor growth twice as long as place...
• Genentech, Biogen Say Rituxan Fails in Lupus Study
CHICAGO (Reuters) - Genentech Inc <DNA.N> and Biogen Idec Inc <BIIB.O> said on Tuesday a key study of Rituxan did not meet its main go...
• Merck shares fall on FDA drug rejection, Abbott shares rise (AP)
Merck & Co. shares fell Tuesday after the Food and Drug Administration rejected the drugmaker's cholesterol drug Cordaptive, marking the company's sec...
• Discovery shares plunge on delay for key drug candidate (AP)
Discovery Laboratories Inc. shares plunged Friday after its key drug candidate faced another regulatory delay with the Food and Drug Administration, f...
• Cephalon shares fall ahead of FDA panel on pain drug Fentora (AP)
Cephalon Inc. shares fell Friday over concerns that the biotechnology company may face a tougher-than-expected Food and Drug Administration panel revi...
• Out of the Gate: QLT climbs after RBC upgrades (AP)
Shares of QLT Inc. rose Thursday after an RBC Capital Markets analyst upgraded the drug maker, saying it is underpriced given a recent divestiture and...
• Progenics stock leaps as drug wins approval
Shares of Eastview-based Progenics Pharmaceuticals Inc. soared yesterday after the company won its first U.S. approval for a product, a drug to ease c...
• Opening Glance: Shares of gold miners decline (AP)
Shares of gold-mining companies fell Thursday shortly after the opening bell, along with the broader stock market. Gold traded in London at $900.75 pe...